Case Review Form

      * Denotes required field.


      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address




      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Tennessee Resident Files Actos Bladder Cancer Lawsuit

Filed July 3rd, 2012 Laurie

Parker Waichman LLP has filed a lawsuit on behalf of a Tennessee resident who claims the drug Actos caused him to develop bladder cancer. Defendants in the case include Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceutical Company Limited and Eli Lilly and Co.

It is pending in the multidistrict litigation as part of In Re: Actos (Pioglitazone) Products Liability Litigation. Jerrold S. Parker, founding partner of Parker Waichman, has been appointed to the Plaintiff’s Steering Committee.

According to the complaint, the plaintiff took Actos from approximately 2002 to 2011, and alleges that it caused the man to develop bladder cancer in 2004. The plaintiff claims Actos caused severe mental and physical pain and suffering, past and future permanent injuries and emotional distress, economic loss due to medical expenses and living related expenses as a result of a new lifestyle. The lawsuit is also seeking compensation on behalf of the patient’s wife for loss of consortium.

The complaint states that the plaintiff never would have taken Actos if he had been aware of its severe health risks.
It alleges the makers of the drug knew or should have known about the risks associated with Actos, especially the risk of bladder cancer following a year of use.

The suit states that because the defendants failed to warn of such risks, patients have been unnecessarily exposed to bladder cancer.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!